Top Tech Companies (764)
Don't see your company?
Create a company profile
CiiTA is provides expertise and actionable intelligence to pharmaceutical and biotechnology manufacturers.
Optimizing Health by Advancing the Quality of Medication Use.
CONTINUUS’ mission is to produce high-quality drugs that can be delivered to patients more effectively and at a lower cost. In achieving this goal, we look to radically transform the pharmaceutical manufacturing industry, steering it away from outdated batch systems to state-of-the-art continuous processes. CONTINUUS is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. With ICM, we will improve affordability and accessibility of pharmaceuticals on a global scale. Our work is critical because the current manufacturing systems are time- and cost-inefficient, and are beset with quality problems. It is not unusual for manufacturing lead times, from start to finish, to be over one year, and studies have shown that the industry loses over $50 B annually due to wasteful processes. More importantly, these problems impact patient care. Hundreds of drugs are placed on the US FDA drug shortage website, many of which are life-saving (e.g., oncology drugs). To solve these problems, we offer a number of solutions: In addition, CONTINUUS is currently collaborating with hospital systems and pharmacy chains to establish its own generic business, where high-quality, low-cost drugs will be manufactured in the United States. To achieve our goals, CONTINUUS has assembled a team of talented engineers and scientists, with skills ranging from analytical chemistry to drug formulation. Rather than producing medicines through batch-wise, step-by-step processes, ICM allows for fully continuous and automated operations, where the synthesis of the active ingredient and the final dosage form are integrated into a seamless process. This novel method will allow “on-demand” manufacturing of pharmaceuticals, improving affordability and accessibility of pharmaceuticals on a global scale.
MedAware Systems, Inc. is a next generation medical research data company that empowers Pharma and Medical Device companies with all available evidence from published clinical trials research, event reporting repositories, and social media. The Company utilizes a combination of Human and Artificial Intelligence to make the vast body of data instantly available and indispensable for fully understanding the safety and efficacy of medical treatments and devices. We support Pharma and Medical Device companies who require complete and timely data and analysis: - for post market monitoring of products across all three verticals: event reporting databases, medical literature, and social media - to satisfy government regulations for evidence of safety and efficacy - to provide the most thorough and granular literature search and analysis for company or product acquisition due diligence - to provide complete and granular competitive analyses - to create powerful, evidence-based marketing messages - to understand what has been done in the past prior to development of new drugs, devices, and therapies. Thoroughly understanding what has been researched results in invaluable information needed to avoid costly mistakes or missteps. http://www.medawaresystems.com
Waltz Health is a Chicago-based technology startup that is leading a new way forward for prescription care. We're rethinking the pharmaceutical supply chain, introducing AI-driven marketplaces that drive down costs, and new consumer tools that guide decisions on care. Led by a team of industry experts, Waltz is fixing the high costs and broken experiences that define our pharmaceutical supply chain. We believe that better pricing, more information and smarter tools can lower costs, empower consumers and help payers take control of their pharmacy benefits. The technology we are building is the start of a new way of working together - making better outcomes possible for all.
Transforming Healthcare with Innovation Multiplier AI is a leading force in the Healthcare industry, providing cutting-edge solutions to global brands like Galderma, Abbott, Merck, Cipla, Mankind, and more. With a team of 70+ dedicated professionals, we specialize in Generative AI, data insights, and physician influencer marketing, driving growth and transformation in the Healthcare landscape. Our Expertise: Generative AI and Personalized Marketing Our expertise lies in harnessing the power of Generative AI to create personalized, impactful marketing campaigns. Through advanced algorithms, we generate compelling content, captivating visuals, and optimized messaging that resonate with target audiences, maximizing engagement and impact. Data Insights: Uncovering Opportunities for Growth By extracting valuable insights from complex datasets, we enable our clients to make informed decisions and drive business growth. Our data-driven approach uncovers hidden patterns, identifies market trends, and keeps our clients ahead of the competition. Physician Influencer Marketing: Building Credibility and Thought Leadership We understand the influential role of physicians in the Healthcare industry. With our specialized physician influencer marketing services, we connect Pharma companies with influential doctors who shape opinions and drive brand awareness. Through strategic partnerships with key opinion leaders (KOLs), we help clients build credibility, establish thought leadership, and enhance brand reputation. Join us in Transforming Pharma & Healthcare To know more contact : US: 1-925-217-7578 India: (+91)- 9100379991 Email: [email protected] Website: https://multipliersolutions.com/
Elevate Healthcare is a strategic communications agency specializing in shaping and translating product objectives into actionable sales and marketing strategies that drive commercial results for our pharmaceutical, biotech, and medical device clients. Early on, Elevate recognized that identifying the best solutions for its clients could be achieved more efficiently and successfully with a leaner, more experienced senior team of strategists who bring immediate value in a highly focused manner. This requires top people from multiple disciplines all working together to provide a comprehensive view of the complexities of a dynamic healthcare landscape to more quickly identify business and brand opportunities that can have a significant impact on a client’s business, then translate, transform, and elevate the promise of those opportunities into real-world success. This is particularly true for challenger brands, an area of expertise for Elevate.
Amplyx focuses on developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems
At Elanco, we work to improve the health of animals through innovative products and services for pets and farm animals around the world. As a global animal health company, we provide solutions that empower our customers to advance a vision of Food and Companionship Enriching Life. Since 1954, Elanco has committed to empowering veterinarians, farmers, and all those who care for animals with the tools they need to help animals live healthy lives. Healthier animals are the key to making our lives better - This is the fundamental belief uniting all global Elanco employees. That’s why we are committed to the idea that our business can be a unique force for good for all in society. Through our Elanco Healthy Purpose™ framework of Environmental, Social and Governance (ESG) commitments, we focus on delivering sustainable solutions to advance the well-being of animals, people and the planet. This program also enables our employees around the world to take paid time off to make an impact as a volunteer, offering their time or talent to give back to our customers, causes and communities. #ElancoHealthyPurpose #WeAreElanco
Invenra is focused on developing the next generation of best-in-class biologics, with an emphasis on multispecific antibodies and their derivatives. Invenra's proprietary technologies combine our highly developable B-Body™ bispecific platform with high throughput functional screening, enabling the optimization of unprecedented numbers of bispecific antibodies in phenotypic assays. Invenra has a pipeline of immuno-oncology bispecific antibodies that are currently in preclinical studies.
.jpeg)
.png)
Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics for non-alcoholic steatohepatitis (NASH), a liver disease with high unmet medical need. Madrigal’s lead candidate, resmetirom, is a once daily, oral, thyroid hormone receptor (THR)-β selective agonist that is designed to target key underlying causes of NASH in the liver. Resmetirom is currently being evaluated in two Phase 3 clinical studies, MAESTRO-NASH and MAESTRO-NAFLD-1, designed to demonstrate multiple benefits in patients with NASH. For more information, visit www.madrigalpharma.com
A pharmaceutical company focused on developing innovative chemistry to detect diseases that involve the presence of amyloid proteins.
Allostatix is an innovative, science-based company providing a breakthrough health risk assessment to help determine how life’s daily
EternaTear is developing a next-generation therapy for the over-the-counter dry eye market.
We are Körber – an international technology group with about 10,000 employees, more than 100 locations worldwide and a common goal: We turn entrepreneurial thinking into customer success and shape technological change. In the Business Area Pharma we deliver the difference along the entire pharmaceutical value chain by offering a unique portfolio of integrated solutions. Based on in-depth experience, we understand the challenges in pharmaceutical processes and regulation that our customers face day to day, from the beginning to the end of their production. • Consulting As the personal partner and pharma technology expert, Körber delivers industry leading consultancy supporting you from requirement analysis to project implementation. • Inspection With world leading high-performance inspection machines, semi-automatic and laboratory equipment and inspection applications, Körber offers an unrivaled level of quality for customized inspection solutions. • Handling With complete handling systems for pharmaceutical and medical products, Körber delivers automated, flexible and secure product transport and tray systems. • Track & Trace As the partner for integrated Track & Trace solutions from level 1 to level 5, Körber delivers the difference through coding, serialization and aggregation to data management all from one source. • Packaging machines As a leading supplier of primary and secondary pharmaceutical packaging machines, Körber delivers the difference by maximizing the OEE of your lines and providing flexibility to address future market requirements. • Software With our world leading PAS-X Manufacturing Execution System (MES) and software solutions, Körber delivers the difference by unlocking the potential of pharmaceutical and biotech value chains. • Packaging materials As the specialist in pharmaceutical cardboard packaging, Körber delivers innovative and high-quality packaging solutions that make the difference.
Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
A location based software platform for healthcare applications.
Lannett Company, Inc. develops, manufactures and distributes generic prescription pharmaceutical products in tablet.
Procter & Gamble Company is an American multi-national consumer goods corporation. P&G was founded over 180 years ago as a soap and candle company. Today, we’re the world’s largest consumer goods company and home to iconic, trusted brands, including Always®, Charmin®, Braun®, Fairy®, Febreze®, Gillette®, Head & Shoulders®, Oral B®, Pantene®, Pampers®, Tide®, and Vicks®. The design, development, growth and success of these products—and many more—is thanks to the innovative and insightful minds of our people. From Day 1, you’ll help make everyday life easier for our 5 billion consumers through billion dollar brands. With our large global footprint, there are many opportunities to work with P&G in multiple locations. We offer opportunities in approximately 70 countries and continually aim to attract, reward and advance the finest people in the world. As a "build from within" organization, we see 95% of our people start at an entry level and progress through the organization. Here, we want you to get your career off to a fast start. That's why we don't have any rotational development programs or gradual ramping-up periods: you’ll be able—and encouraged—to dive right in from day 1. Join us and help make life better through meaningful work that makes an impact from Day 1.
Segal Trials, founded in 1998, is a privately held network of seven research sites throughout South Florida conducting Phase I-IV research trials with a primary emphasis on psychiatry, neurology, addiction, insomnia, general medicine, healthy volunteers, infectious diseases, vaccines, and women’s health. Staying true to its core values of quality, customer service, advocacy, and patient care, the Segal Trials team of over 110 professionals remains agile and competitive, expanding and growing based on the needs of its sponsors and its patients. Federal law requires that every medication must go through a series of clinical research trials before being approved by the FDA, in addition to being approved by an independent Research Ethics Board. Clinical research trials are critical in the advancement of medicine and making available new and helpful medications. It is Segal Trials’ mission to play an integral role in the advancement process and help millions of people suffering from diseases.
